lenalidomide has been researched along with AIDS-Associated Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, NK; Mannis, GN; Rubenstein, JL; Wang, CC; Yu, JJ | 1 |
| Jain, N; Malhotra, P; Prakash, G; Sahu, KK; Saikia, U; Yanamandra, U | 1 |
2 other study(ies) available for lenalidomide and AIDS-Associated Lymphoma
| Article | Year |
|---|---|
Regression of methotrexate-resistant AIDS-related primary central nervous system lymphoma with lenalidomide plus combination anti-retroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Central Nervous System Neoplasms; Drug Resistance, Viral; Female; Humans; Lenalidomide; Lymphoma, AIDS-Related; Thalidomide; Treatment Outcome | 2017 |
Plasmablastic lymphoma: successful management with CHOP and lenalidomide in resource constraint settings.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lenalidomide; Lymphoma, AIDS-Related; Maxillary Sinus Neoplasms; Plasmablastic Lymphoma; Poverty; Prednisolone; Remission Induction; Thalidomide; Vincristine | 2016 |